New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
Abstract House-dust mites (HDM) allergy is the prevailing condition in subjects allergic to inhalants. Clinical studies with HDM extracts—either subcutaneous (SCIT) or sublingual (SLIT) have long been characterized by small sample size, varying allergen doses, and poorly defined endpoints assessing...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-06-01
|
| Series: | Clinical and Molecular Allergy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12948-020-00124-7 |